BUY Fortis HealthcareNomura India Research

byNomura India ResearchHorizon: NA (inferred 1 year)7 Sept 2026via CNBC Awaaz.

Entry₹902.1Inferred
Target₹1,030
Total upside +14.18%
Stop lossNot given
CMP₹910Just now
Active+0.88%+13.19%upside left 12 mo left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 9:01 am IST
13 supporting8 neutral3 opposing

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.